花旗银行：2023年抗菌素耐药性报告（英文版）（108页）.pdf

1、Citi is one of the worlds largest financial institutions,operating in all major established and emerging markets.Across these world markets,our employees conduct an ongoing multi-disciplinary conversation accessing information,analyzing data,developing insights,and formulating advice.As our premier

2、thought leadership product,Citi GPS is designed to help our readers navigate the global economys most demanding challenges and to anticipate future themes and trends in a fast-changing and interconnected world.Citi GPS accesses the best elements of our global conversation and harvests the thought le

3、adership of a wide range of senior professionals across our firm.This is not a research report and does not constitute advice on investments or a solicitations to buy or sell any financial instruments.For more information on Citi GPS,please visit our website at GPS:Global Perspectives&Solutions Dece

4、mber 2022ANTIMICROBIAL RESISTANCEThe Silent Pandemic Citi GPS:Citi GPS:Global Perspectives&Solutions December 2022 Authors Anita McBain Head of ESG Research,EMEA Citi Research +44-20-7508-4361| Amy Thompson Senior Research Associate Citi Global Insights +44-20-7986-3542| Andrew Baum,MD Global Head o

5、f Healthcare Research Citi Research +44-20-7986-4498| Veronika Dubajova Head of MedTech&Healthcare Services,EMEA Citi Research +44-20-7986-4585| Georgina Smartt ESG Analyst,EMEA Citi Research +44-20-7500-0708| Makanjuola Senbanjo ESG Research Associate,EMEA Citi Research +44-20-7508-4593| Prof.Timot

6、hy R.Walsh OBE Director of Biology Ineos Oxford Institute for Antimicrobial Research Lord Jim ONeill of Gatley Crossbench Peer House of Lords Prof.Dame Sally C.Davies U.K.Special Envoy on Antimicrobial Resistance Dr.Damiano de Felice Director of Development&External Engagement,CARB-X Abigail Herron